GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Innova Captab Ltd (BOM:544067) » Definitions » Debt-to-Equity

Innova Captab (BOM:544067) Debt-to-Equity : N/A (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Innova Captab Debt-to-Equity?

Innova Captab's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil. Innova Captab's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil. Innova Captab's Total Stockholders Equity for the quarter that ended in Dec. 2024 was ₹0 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Innova Captab's Debt-to-Equity or its related term are showing as below:

BOM:544067' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.29   Med: 0.86   Max: 2.81
Current: 0.29

During the past 6 years, the highest Debt-to-Equity Ratio of Innova Captab was 2.81. The lowest was 0.29. And the median was 0.86.

BOM:544067's Debt-to-Equity is ranked worse than
50.54% of 827 companies
in the Drug Manufacturers industry
Industry Median: 0.28 vs BOM:544067: 0.29

Innova Captab Debt-to-Equity Historical Data

The historical data trend for Innova Captab's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innova Captab Debt-to-Equity Chart

Innova Captab Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Equity
Get a 7-Day Free Trial 0.87 0.31 0.96 0.86 0.30

Innova Captab Quarterly Data
Mar19 Mar20 Mar21 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 0.30 N/A 0.29 N/A

Competitive Comparison of Innova Captab's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Innova Captab's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innova Captab's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Innova Captab's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Innova Captab's Debt-to-Equity falls into.



Innova Captab Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Innova Captab's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Innova Captab's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innova Captab  (BOM:544067) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Innova Captab Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Innova Captab's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Innova Captab Business Description

Traded in Other Exchanges
Address
SCO No. 301, Sector 9, Second Floor, Panchkula, HR, IND, 134109
Innova Captab Ltd is an integrated pharmaceutical company in India and is engaged in research and development, manufacturing, drug distribution, and marketing and exports. Company business includes (i) a contract development and manufacturing organization ("CDMO") business providing manufacturing services to Indian pharmaceutical companies, (ii) a domestic branded generics business, and (iii) an international branded generics business.

Innova Captab Headlines

No Headlines